NEW DELHI: The Government of India has launched ‘Mission COVID Suraksha’ to help hasten the advancement of nearly 4-6 vaccine candidates and guarantee that these are brought nearer to licensing and introduction in the market, the Department of Biotechnology (DBT) said on Wednesday, November 25. DBT also said that the mission estimates COVID-19 vaccine advancement with end-to-end focus from preclinical through clinical development and manufacturing and regulatory facilitation.
The government has also announced a package of Rs 900 crore for the mission. This grant will be given to DBT for research and advancement of Indian COVID-19 vaccines. The main objectives of the grant will be to hasten the pre-clinic and clinical development, licensing of COVID-19 vaccine candidates that are at the moment in clinical stages or ready to enter clinical stages. It also aims to institute clinical trial sites and improve the existing immunoassay laboratories, central laboratories, production facilities and other facilities to boost the COVID-19 vaccine development.